Abstract
A 35-year-old woman with biopsy-proven recurrent Hodgkin lymphoma in the neck lymph nodes received salvage chemotherapy of brentuximab/insulin growth factor-methotrexate. Although the patient continued doing well clinically with no constitutional symptoms or significant laboratory abnormalities following the second recurrence, subsequent FDG PET CT examinations over the next 2 years revealed multiple new FDG-avid foci including lymph nodes above/below the diaphragm, liver, spleen, lungs, and bone. An alternate diagnosis of chemotherapy-induced sarcoidosis was suggested and confirmed on both bone marrow and right inguinal node biopsy.
Original language | English (US) |
---|---|
Pages (from-to) | 702-703 |
Number of pages | 2 |
Journal | Clinical nuclear medicine |
Volume | 42 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2017 |
Externally published | Yes |
Keywords
- FDG PET/CT
- Hodgkin lymphoma
- chemotherapy-induced sarcoidosis
- sarcoidosis
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging